Physician profile
Farshad Elmi
NPI 1477535797
$1,993.11
in general payments reported to CMS, 2019-2025
17 companies · $60.84 in 2025
The $60.84 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $66.52 · 2021: $477 · 2022: $232 · 2023: $775 · 2024: $118 · 2025: $60.84.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $954.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $720.67 | 2019-2025 | |
| Boston Scientific Corporation | $459.70 | 2021-2023 | Exalt Model D |
| Genzyme Corporation | $185.11 | 2023 | |
| Pfizer INC. | $160.22 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $98.38 | 2021 | |
| Ironwood Pharmaceuticals, INC | $68.54 | 2023-2024 | Linzess |
| Axonics, INC. | $66.52 | 2020 | |
| Braintree Laboratories, INC. | $48.52 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.30 | 2021-2022 | |
| Cook Medical LLC | $28.31 | 2019 | |
| Currax Pharmaceuticals LLC | $24.39 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.75 | 2021 | |
| Ferring Pharmaceuticals INC. | $17.50 | 2019 | |
| Capsovision, INC. | $17.49 | 2024 | Capsocam Plus |
| Olympus America INC. | $17.35 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $11.76 | 2021 | |
| Romark Laboratories, Lc | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farshad Elmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.